Drawing for SYNTHIA

USPTO serial 87825579

SYNTHIA

Reviewed by CopyMark Law Group

Reg. 7575011Status 700Registered
Filing date
Status date
Registration date
Nov 26, 2024
Examiner
HOWELL, MATTHEW P
Law office
TMO LAW OFFICE 123

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNTHIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright EPSTEIN DRANGEL LLP60 EAST 42ND STREET, SUITE 2520NEW YORK, NY 10165United States

Goods and services

ClassDescriptionStatusFirst use
009Electronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for computer-aided molecular design, data processing and data analysis for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; chemical data analysis software for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancyACTIVE—
038Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancyACTIVE—
042Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancyACTIVE—
045Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 26, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 15, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 13, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 15, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 15, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 15, 2024CNSISUSPENSION INQUIRY WRITTEN—
Apr 12, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 11, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 11, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 3, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 2, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 14, 2023DOCKASSIGNED TO EXAMINER—
Nov 30, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 28, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 28, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Apr 28, 2022CNSLSUSPENSION LETTER WRITTEN—
Feb 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2021DOCKASSIGNED TO EXAMINER—
Aug 23, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 23, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 22, 2020ALIEASSIGNED TO LIE—
Dec 20, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 10, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 10, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jun 10, 2019CNSLSUSPENSION LETTER WRITTEN—
May 20, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 20, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2019ALIEASSIGNED TO LIE—
May 9, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 19, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 19, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Mar 19, 2019CNSLSUSPENSION LETTER WRITTEN—
Mar 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 2, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 2, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2018DOCKASSIGNED TO EXAMINER—
Mar 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance